Biotech | March 22, 2022
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
The drug is indicated for use in combination with other drugs
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
The facility will produce 150 million vaccine doses per year
Subscribe To Our Newsletter & Stay Updated
